Correlation Between Champions Oncology and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Champions Oncology and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Mineralys Therapeutics,.
Diversification Opportunities for Champions Oncology and Mineralys Therapeutics,
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Champions and Mineralys is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Champions Oncology i.e., Champions Oncology and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Champions Oncology and Mineralys Therapeutics,
Given the investment horizon of 90 days Champions Oncology is expected to generate 1.23 times more return on investment than Mineralys Therapeutics,. However, Champions Oncology is 1.23 times more volatile than Mineralys Therapeutics, Common. It trades about 0.25 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.13 per unit of risk. If you would invest 820.00 in Champions Oncology on November 3, 2024 and sell it today you would earn a total of 279.00 from holding Champions Oncology or generate 34.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Champions Oncology |
| Mineralys Therapeutics, |
Champions Oncology and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Mineralys Therapeutics,
The main advantage of trading using opposite Champions Oncology and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |